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Abstract
Background
Due to improved treatment, there is an increasing focus on the reproductive potential of sur-
vivors of childhood cancer. Cytotoxic chemotherapy accelerates the decline in the number
of primordial follicles within the mammalian ovary at all ages, but effects on the developmen-
tal potential of remaining oocytes following prepubertal cancer treatment are unclear.
Objectives
To investigate whether cyclophosphamide (CY) exposure in the prepubertal period in
female mice influences ovarian function and the functional competence of oocytes in
adulthood.
Methods
This study used Swiss albino mice as the experimental model. Female mice were treated
with 200 mg/kg CY on either postnatal day 14 (CY14), 21 (CY21) or 28 (CY28) i.e at a prepu-
bertal and 2 young postpubertal ages. At 14 weeks of life, ovarian function, functional com-
petence of oocytes, and embryo quality were assessed.
Results
The number of primordial follicles decreased significantly in CY14 and CY21 groups com-
pared to control (p < 0.01). The number of oocytes from superovulated was 8.5 ± 1.4, 24.1 ±
2.9 and 26.8 ± 2.1 in CY14, CY21 and CY28 respectively which was significantly lower than
control (50.2 ± 3.2; p < 0.001). In vitro culture of CY14 embryos demonstrated only 55.4%
blastocyst formation (p < 0.0001) and reduced ability of inner cell mass (ICM) to proliferate
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in vitro (p < 0.05) at 120 and 216 h post insemination respectively. On the other hand, ICM
proliferation was unaltered in 2 young postpubertal ages.
Conclusion
Our results indicate long-term effects on the developmental competence of oocytes
exposed to CY in early but not adult life. These data provide a mechanism whereby long-
term fertility can be impaired after chemotherapy exposure, despite the continuing presence
of follicles within the ovary, and support the need for fertility preservation in prepubertal girls
before alkylating agent exposure.
Introduction
Childhood cancer survival has improved greatly over the past five decades, and due to
improved treatment modalities, about 70–80% of children with cancer will be cured. Many
childhood cancer survivors are now entering their reproductive age [1]. However, certain
types of cancer treatments can compromise ovarian function in children, notably high doses of
alkylating agents and radiotherapy [2–4].
Cyclophosphamide (CY) is an alkylating chemotherapeutic agent commonly used to treat
solid and haematological malignancies, and autoimmune disorders. The primary target of CY
in murine ovaries is the growing follicles with additional direct and indirect effects on primor-
dial follicles [5–7]. Oocytes within primordial follicles exist in a relatively quiescent state, and
hence may be relatively resistant to antimitotic agents [8], but the effects of alkylating agents
are independent of the cell cycle. On the other hand, recent studies have shown that CY is also
capable of damaging the primordial follicles in murine ovaries [7,9]. Rodents exposed to CY in
pregnancy (i.e. before primordial follicle formation) also showed a reduced number of primor-
dial follicles and increased follicle growth activation in the offspring [10].
The ovaries have a finite number of primordial follicles at birth, with this constituting the
ovarian reserve. The irreversible decline in the number of primordial follicles within a prepu-
bertal ovary starts as soon as follicles begin to form and this process continues till menopause.
The decline in the primordial follicle pool is accelerated when girls and women undergo cyto-
toxic chemotherapy, leading to premature ovarian insufficiency (POI) and infertility [11,12]. It
has been shown that cancer chemotherapy significantly damages prepubertal ovaries, causes
follicle maturation arrest, induces stromal fibrosis, and decreases the number of oocytes.
These effects have been seen with the administration of just a single dose of alkylating chemo-
therapy agent [13].
While chemotherapy treatment can induce a complete loss of ovarian function (POI), there
is also evidence that women are more likely to report infertility after both adult and childhood
cancer treatment, even when there is ongoing ovarian function [14,15]. This may indicate
damage to follicles and oocytes that is insufficient to cause their loss, but may reduce their
developmental competence. The prepubertal ovary contains populations of follicles and
oocytes with abnormal morphology that are not found in the adult ovary, and isolated follicles
show different growth characteristics [16] and in mouse, the prepubertal ovarian environment
undergoes significant transformation before and on entering puberty [17]. Thus, the prepuber-
tal period is a time of ongoing maturation towards adult ovarian function, rather than just rela-
tive quiescence. Additionally, younger oocytes may have greater capacity for DNA repair and
therefore be able to respond to toxic insults to a greater extent than older ones [18].
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Therefore, understanding the impact of chemotherapeutic agents on prepubertal ovaries is
important in addressing the risk of abnormal reproductive outcomes in childhood cancer sur-
vivors in their adult life. The long-term nature of these studies and the difficulties in studying
oocyte function in the human require the use of animal models. Using the mouse, we have
examined the functional competence of female germ cells exposed to CY, comparing early pre-
pubertal exposure with exposure in other groups. When prepubertal (14 day old) mice were
exposed to CY, our results indicate impairment in ovarian function and gamete quality leading
to poor embryonic development.
Materials and methods
Animals and experimental design
All experiments and animal handling were conducted in accordance with the institutional
guidelines for animal experimentation after obtaining prior approval from the Institutional
Animal Ethics Committee (Kasturba Medical College & Kasturba Hospital Institutional Ethics
Committee, approval #IAEC/KMC/61/2016 & IAEC/KMC/21/2018). The animals were
housed and maintained in controlled conditions of 23 ± 2˚C, 12 h light-dark cycle, 50 ± 5%
humidity, and were fed with standard diet and water ad libitum.
The experimental design involved treatment of a total of one hundred and three healthy
female siblings from 24 litters, where ninety-one siblings were divided into groups for CY
exposure on either postnatal day 14, postnatal day 21 or postnatal day 28 (CY14, CY21 &
CY28 respectively), and twelve siblings were used as control. The CY animals were weighed on
either day 14 (N = 54), day 21 (N = 21), or day 28 (N = 16) and administered a single intra-
peritoneal injection of 200 mg/kg CY (C7397, Sigma Aldrich, USA), the control mice received
an equal volume of phosphate buffer saline (PBS) on day 14, 21 and/or 28 and grouped as ran-
domized control (N = 12). The CY exposed female mice were monitored every week for fur
loss, change in body weight and survival. A recovery period post-treatment was decided on the
ability of the animal to overcome the CY dose in terms of fur loss, gain in body weight and sur-
vival. A minimum body weight of 20 g was set as standard before considering them as fit for
ovarian stimulation. Therefore, at 14 weeks of life, irrespective of post-treatment interval, the
surviving animals were superovulated as described below.
Ovarian stimulation
Female mice were superovulated by the intra-peritoneal injection (5 IU) of pregnant mare
serum gonadotropin (PMSG, Sigma Aldrich, USA) followed by the administration of 10 IU of
human chorionic gonadotropin (hCG, Eutrig-HP) after 48 h. The animals were weighed and
euthanized 13 h post hCG by cervical dislocation. Oocyte Cumulus Complexes (OCCs) were
collected from the oviduct.
Ovarian histology
Extracted ovaries were weighed and either fixed in Bouin’s solution for histological analysis.
The other ovary from each animal was gently teased (cortical region) under a stereomicro-
scope using fine needles to release GV oocytes from the secondary/tertiary follicles. The fixed
ovaries were then paraffin-embedded and cut into 5 μm sections on slides. After deparaffiniza-
tion and rehydration, the sections were stained with Haematoxylin and Eosin (H&E) and
examined for the number of primordial, primary, secondary and antral follicles under light
microscopy. Only those follicles in which the nucleus of the oocyte was clearly visible were
scored. Primordial follicles had an intact oocyte surrounded by a single layer of flattened
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squamous follicular cells, primary follicles had an intact oocyte surrounded by a single layer of
cuboidal follicular or supporting cells, secondary follicles had an intact oocyte surrounded by
multiple layers of follicular or supporting cells and antral follicles had an intact oocyte with
multiple layers of granulosa cells, a basal lamina, a theca interna and a theca externa with fluid-
filled cavity. The histological analysis was performed by assessing the follicle count and imag-
ing. A minimum of 4 ovaries were taken per group and the follicle data are presented in Figs 1
and S1.
Hormone measurements
Antimullerian hormone (AMH) levels in serum were measured by Electrochemiluminescence
Immunoassay (ECLIA) using a COBAS e411 analyzer using the specified kit with a detection
range of 0.01–23 ng/mL (Roche, Mannheim, Germany). The values are expressed as ng/mL
serum.
Mitochondrial activity in metaphase II oocytes
The mitochondrial activity was estimated as described earlier [19]. Briefly, the denuded meta-
phase II (MII) oocytes were washed and incubated with freshly prepared 1 μg/mL 5,50,6,60-
tetrachloro-1,10,3,30-tetraethylbenzimidazolylcarbocyanine iodide (JC-1, T3168, Molecular
probes, Life technologies, USA), at 37˚C for 30 min. The oocytes were later washed in DMEM
medium (supplemented with 1mg/mL of bovine serum albumin) and imaged for JC-1 mono-
mers and JC-1 aggregates detection, using a fluorescence microscope (Imager-A1, Zeiss, Got-
tingen, Germany). The ratio of orange and green fluorescence was calculated using ImageJ
software (National Institute of Health, Bethesda, Maryland, USA).
Fig 1. Prepubertal CY exposure on ovary at 14 weeks of life (a-d) Representative images of histological examination: control, CY14, CY21 & CY28, respectively.
The scale bar represents 50 μm. (e) Mean (± SEM) number of primordial follicle per ovary section examined, in control (N = 9), CY14 (N = 7), CY21 (N = 4) & CY28
(N = 6), ��p< 0.01 vs. control. (f) Number of GV oocytes retrieved from stimulated ovaries, in control (N = 6), CY14 (N = 18), CY21 (N = 16) & CY28 (N = 14),
���p< 0.001 vs. control. (g) AMH level in blood serum (N = 5 per group), �p< 0.05 & ��p< 0.01 vs. control. (h) Mean (± SEM) total number of oocytes, post
superovulation, in control (N = 6), CY14 (N = 18), CY21 (N = 16) & CY28 (N = 14) females, ���p< 0.001 vs. control.
https://doi.org/10.1371/journal.pone.0235140.g001
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In vitro fertilization and preimplantation embryo development
In vitro fertilization and embryo culture were carried as described earlier [20]. OCCs from the
oviduct were released into pre-warmed Earl’s balanced salt solution (EBSS, E2888, Sigma
Aldrich, USA) supplemented with 0.1% bovine serum albumin (BSA). Cumulus-intact oocytes
were inseminated with capacitated spermatozoa (final concentration: 3–5×105 spermatozoa/
mL) collected from the healthy males. The gametes were co-incubated for 12 h at 37˚C in 5%
CO2. The oocytes were then washed in Potassium Simplex Optimization Medium (KSOM
AA), and classified as normally fertilized (having 2 pronuclei and 2 polar bodies) or abnormal
(no pronuclei, dead or fragmented). Fertilized oocytes were transferred to fresh KSOM, and
cultured until the blastocyst stage. Their developmental potential was assessed under an
inverted microscope (IX73, Olympus, Japan) at regular intervals to assess 2-cell, 4-cell, morula
and blastocyst rate. For total cell number (TCN), the expanded and hatched blastocysts were
fixed in 4% paraformaldehyde for 1 h. The blastocysts were then washed 3 times in phosphate
buffered saline (PBS) and the nucleus stained using 4 μg/ml DAPI. They were transferred to
clean microscopic slides and total cell number per blastocysts was documented under fluores-
cent microscope (Carl Zeiss, Gottingen, Germany).
Inner Cell Mass (ICM) outgrowth assay
Ability of the blastocyst to attach and proliferate post-implantation in vitro was assessed using
ICM outgrowth assay. In vitro derived blastocysts appearing morphologically normal with
expanded blastocoel at 120 hour-post insemination (hpi) were selected for ICM outgrowth
assay [21,22]. Briefly, multi-well dishes (D7039, Sigma Aldrich, USA) were pre-coated with
gelatin (0.1%) for 30 min at room temperature. Excess gelatin was removed and the dishes
were air dried. Individual blastocysts at 120 hpi were transferred into each well containing
500 μL Dulbecco’s Modified Eagle Medium (DMEM) 20% supplemented with fetal calf serum
(FCS). The embryos were cultured in vitro for an additional extended period of 96 h i.e. till 216
hpi. The medium was changed after 48 h of culture and proliferation of inner cell mass and
trophectoderm was monitored under an inverted phase contrast microscope (IX73, Olympus,
Japan) at the end of culture. Based on morphology and size of the outgrowths, ICM out-
growths (IO) were graded as completely developed ICM outgrowth (CIO), large ICM out-
growth (LIO), small ICM outgrowth (SIO), and no ICM outgrowth (NIO), as described earlier
[21]. The ICM and trophectoderm (TE) area were quantified using ProgRes CapturePro (ver-
sion 2.7.7, Jenoptik, Germany) and presented.
Statistical analysis
All data are presented as mean±SEM, and analysed using either by One Way Analysis of Vari-
ance (ANOVA) for data normally distributed, or by Kruskal-Wallis test followed by Dunn’s
test if not normally distributed. Percentage data for preimplantation embryo development and
ICM outgrowth assay was analyzed using Chi-square test, all tests performed using GraphPad
InStat 3.0 statistical package (GraphPad Inc., USA). All the graphs were plotted using Origin
8.0 (Origin Lab Corporation, Northampton, MA, USA).
Results
Effect of prepubertal CY exposure on survival
The intra-peritoneal administration of CY at 200 mg/kg body weight resulted in reduced sur-
vival, with the effect reducing with increasing age at treatment [control: 100% survival vs.
CY14: 61.1% (p< 0.05), CY21: 76.2%, CY28: 87.5%]. Survival was monitored up to 14 weeks
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of life (Table 1). The general health of the animals, in terms of weight of various organs, did
not change significantly except the liver weight in CY14 (p< 0.01) and CY21 (p< 0.05). Fur-
thermore, the ovarian weight was significantly lower in all CY groups (p< 0.01 vs. control)
and the uterine weight declined significantly in CY14 and CY28 in comparison to control
(p< 0.001) (S1 Table).
Prepubertal CY exposure reduces primordial follicle numbers and
Antimullerian hormone (AMH) level
Examination of ovaries from CY treated animals showed significant alterations in the ovarian
histology (Fig 1A–1D). The number of primordial follicles was decreased significantly in CY14
and CY21 groups (Figs 1E and S1) compared to control (p< 0.01). There were no differences
in the number of primary or antral follicles between groups, although the number of secondary
follicles was significantly lower in CY14 (p< 0.01, S1 Fig) and serum AMH was significantly
lower in CY14 (p< 0.01) and CY21 (p< 0.05) in comparison to control (Fig 1G). Further-
more, the number of germinal vesicle (GV) oocytes retrieved from the secondary/tertiary folli-
cles in the stimulated ovaries was significantly lower in CY14 (p< 0.001) but not in CY21 and
CY28 compared to control (Fig 1F).
Effect of prepubertal CY exposure on ovulation, fertilization and
subsequent embryonic development in vitro
Mice exposed to CY showed a reduced ovarian response to superovulation (Fig 1H and S2
Table). No oocytes were recovered in 45% of animals (N = 15 out of 33) in CY14 group. Ani-
mals not exposed to CY yielded a total of 50.2 ± 3.2 oocytes per animal, of which 86.3 ± 2.6%
oocytes were MII. The total number of oocytes from females responded to superovulation and
the maturation rate of retrieved oocytes in CY14 (8.5 ± 1.4 and 73.9 ± 5.7%), CY21 (24.1 ± 2.9
and 79.6 ± 5.9%) and CY28 (26.8 ± 2.1 and 83.4 ± 3.8%) demonstrated a significant decline in
the number of oocytes (p< 0.001, Fig 1H) but not in maturation rate compared to control.
Mitochondria in oocytes provide energy for fertilization and subsequent preimplantation
development. Here we used JC-1, a mitochondrial specific probe to determine the mitochon-
drial potential in CY treated animals. JC-1 fluoresces red in the presence of active mitochon-
dria by forming aggregates. In the presence of inactive mitochondria as the probe remains in
Table 1. Effect of prepubertal CY exposure on body weight and survival.
Group Females (N) Body weight in g ± SEM (survival) at different weeks of life
2 weeks 3 weeks 4 weeks 5 weeks 10 weeks 14 weeks
Control 12 6.1 ± 0.2 9.4 ± 0.3 14.0 ± 0.5 18.3 ± 0.5 26.5 ± 0.6 27.9 ± 0.4
(100) (100) (100) (100) (100) (100)
CY14 54 6.6 ± 0.2 7.0 ± 0.2 c 9.7 ± 0.3 c 11.6 ± 0.5 c 15.9 ± 0.6 c 24.6 ± 0.6 b
(100) ■ (90.7) (88.9) (85.2) (72.2) (61.1) a
CY21 21 6.2 ± 0.2 10.3 ± 0.4 11.4 ± 0.5 a 14.0 ± 0.9 b 19.3 ± 0.9 b 24.7 ± 0.6 b
(100) (100) ■ (100) (100) (80.9) (76.2)
CY28 16 6.1 ± 0.2 9.1 ± 0.2 14.0 ± 0.3 15.3 ± 0.7 19.8 ± 1.0 a 25.2 ± 0.6 a
(100) (100) (100) ■ (93.8) (87.5) (87.5)
■ Indicates the time of CY injection (single dose of 200 mg/Kg body weight, i.p.).
ap < 0.05,
bp < 0.01,
cp < 0.001 vs. control.
https://doi.org/10.1371/journal.pone.0235140.t001
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the monomeric state and fluoresces green (S2 Fig). However, JC-1 ratio (red to green) was
comparable across all the groups studied (Fig 2A).
The fertilization ability of MII oocytes derived from CY treated animals was tested by
inseminating with caudal spermatozoa collected from healthy males. The fertilization rate did
not differ in CY groups compared to control (Fig 2B). However, the ability of the embryos to
progress to blastocyst was significantly reduced in all CY groups (Table 2). Of the 246 fertilized
eggs in the control group, 87% progressed to blastocyst, and 43.9% embryos hatched at 120
hpi. In CY14, only 55.4% of 92 fertilized eggs formed blastocysts (p< 0.0001) and only 16.3%
of embryos demonstrated hatching (p< 0.0001, Table 2). Similarly, lower rates of blastocyst
formation and hatching were observed in CY21 (70.7%; p< 0.0001 and 31.5%; p< 0.01,
respectively) and CY28 (70.6%: p< 0.0001 and 28.4%: p< 0.001) compared to control. How-
ever, the blastocysts were morphologically indistinguishable across the groups, and no differ-
ence was found in the total cell number (TCN; Fig 2C).
Inner Cell Mass (ICM) proliferation ability but not embryo attachment
potential was affected by CY treatment
As blastocysts derived from CY treated animals were morphologically similar, their ability to
attach to gelatin coated plates and to proliferate in vitro was tested at 120 hpi. Hatched blasto-
cysts attain adhesive capacity by 24h of in vitro culture. The hatching potential and attachment
ability of blastocysts transferred to gelatin coated plates did not differ significantly between the
control and CY groups. However, after culture for 48 h i.e. at 168 hpi, the attached blastocysts
from CY14 showed significant delay in ICM cell proliferation in vitro (17.5±1.5 vs. 64.0±6.9 in
CY28: p< 0.05, Fig 3), whereas proliferation was unaffected in CY21 (51.1±5.9) and CY28
compared to control (53.9±6.1) group. ICM outgrowths were graded morphologically at 96 h,
i.e. 216 hpi (Fig 4A–4D). The number of embryos with completely developed outgrowths
(CIO) was significantly lower in CY14 (17.5±1.7; p< 0.05) and the proportion with no out-
growth was higher in CY14 (19.2±5.6, p< 0.05) compared to control (Fig 4E). However, the
ICM and TE area and the ICM to TE ratio did not significantly differ across the study groups
(S3 Table).
Discussion
The current study indicates that the early prepubertal rodent ovary is more vulnerable to CY
induced reproductive toxicity than the other age groups tested. The extent of the impairments
observed in this study include an expected reduction in the ovarian reserve, but also clearly
show compromised functional ability of the surviving female germ cells when animals attained
Fig 2. Effect of prepubertal CY on oocyte competence at 14 weeks of life (a) mitochondrial activity in MII oocytes,
in control (N = 45), CY14 (N = 22), CY21 (N = 36) and CY28 (N = 58) (b) fertilizing ability of the in vivo matured MII
oocytes in the presence of capacitated caudal spermatozoa from healthy males, in control (N = 270), CY14 (N = 108),
CY21 (N = 324) and CY28 (N = 316) oocytes and (c) total cell number (TCN) in expanded and hatched blastocysts at
120 hpi, in control (N = 33), CY14 (16), CY21 (N = 43) and CY28 (N = 33) blastocysts. No significant difference found
between the study groups.
https://doi.org/10.1371/journal.pone.0235140.g002
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adulthood, with greater impairment following CY exposure at younger ages, thus despite a lon-
ger period for potential recovery.
Table 2. Effect of prepubertal CY exposure on preimplantation development of embryos in vitro.
Groups Fertilized oocytes (N) Preimplantation embryo development rate in vitro (%)
2 cell at 24 hpi 4 cell at 48 hpi Morula at 72 hpi Blastocyst at 120 hpi Hatched blastocyst at 120 hpi
Control 246 244 (99.2) 228 (92.7) 225 (91.5) 214 (87.0) 108 (43.9)
CY14 92 79 (85.9) d 57 (62.0) d 58 (63.0) d 51 (55.4) d 15 (16.3) d
CY21 270 253 (93.7) b 214 (79.3) d 210 (77.8) d 191 (70.7) d 85 (31.5) b
CY28 275 262 (95.3) a 231 (84.0) b 249 (90.5) 194 (70.6) d 78 (28.4) c
ap < 0.05,
bp < 0.01,
cp < 0.001 and
dp < 0.0001 vs. control.
https://doi.org/10.1371/journal.pone.0235140.t002
Fig 3. Effect of prepubertal CY exposure on hatching, attachment and proliferation ability of the blastocysts, after ICM culture at 48 h,
(i.e. at 168 hpi). The data is presented in mean±SEM, of in vitro derived blastocysts hatched, attached or proliferated, in control (N = 112, grey
bar), CY14 (N = 23, blue bar), CY21 (N = 87, yellow bar) & CY28 (N = 99, orange bar). ��p< 0.05 vs. CY28, N = 3 trial. Bar represents mean
and error bar represents standard error of mean.
https://doi.org/10.1371/journal.pone.0235140.g003
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Cytotoxic effects of CY on normal proliferative cells in mice [23], including human ovarian
cells [24] are well-known. It has been shown in the murine model that primordial follicles are
also sensitive to CY toxicity, as are antral and growing follicles [5–7,9,25]. The diminished pri-
mordial follicle numbers in the present study show that prepubertal ovaries are also sensitive
to CY induced follicular depletion. Consistent with many studies showing reduced AMH levels
after childhood cancer therapy [26–28], in the present study AMH was reduced in CY-treated
animals in adulthood, most markedly in CY14. In keeping with these findings, fewer GV
oocytes were obtained after superovulation from CY-exposed animals, again with the most
marked reduction being in CY14, treated at the youngest age.
Preimplantation mouse embryos show unique stage dependent checkpoint responses to
genetic insults whereby p53 mediated checkpoint is active soon after fertilization followed by
several other checkpoint mechanisms to protect embryos [29–31]. The integrity of the genome
is constantly at risk due to the errors intrinsic to DNA replication [29]. It is important to note
that embryos have an efficient DNA damage response pathway after implantation, and this is
crucial for the proper development of the organism during this period [32]. The ability of
oocytes to undergo in vitro fertilization was not significantly altered in CY exposed animals in
comparison to control. However, preimplantation developmental competence was signifi-
cantly reduced in embryos derived from CY14. Importantly, as also shown by the ovarian and
oocyte data, all these effects were more marked in the animals treated at the youngest age, with
reduced impact in more mature animals. In rodents, in vitro embryonic block at the 2-cell
stage is a common phenomenon and causes are multifactorial. Since the embryo progression
from 2-cell to blastocyst stage did not vary significantly across CY exposed groups (Table 2), it
is possible that CY embryos had higher tendency to experience 2-cell block.
Mouse preimplantation embryos carrying induced DNA lesions are morphologically indis-
tinguishable from control embryos at the blastocyst stage [33], and consistent with this,
embryos across the groups were morphologically normal in the present study. Due to limited
damage sensing and repair ability, preimplantation embryos have the tendency to progress
beyond the blastocyst stage despite carrying genetic damage. Hence, we considered assessing
Fig 4. Effect of prepubertal CY exposure on proliferation ability of inner cell mass of blastocysts at 14 weeks of life. (a-d) Representative phase-contrast images of
ICM outgrowths at 216 hpi: CIO, LIO, SIO and NIO respectively. Red arrowhead marks the ICM outgrowths (Scale bar 50 μm). (e) Proportion of ICM outgrowths of in
vitro derived blastocysts graded as CIO (orange bar) and NIO (black bar) after culture for 216 hpi in vitro, of control (N = 112), CY14 (N = 23), CY21 (N = 87) & CY28
(N = 99) transferred blastocysts. �p< 0.05, vs. control, N = 3 trial. Bar represents mean and SEM is represented by error bar.
https://doi.org/10.1371/journal.pone.0235140.g004
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their functional ability beyond the blastocyst stage using the in vitro ICM proliferation ability
assay. Hatched mouse blastocysts attain adhesive capacity by 24 h of in vitro culture [34]. In
our study, the potential of hatched blastocysts to attach was similar in control and CY groups.
However a significant reduction in blastocyst outgrowths was observed in CY14 embryos. In
vivo studies have shown that excessive apoptosis in the ICM compartment of blastocysts may
lead to post implantation demise, possibly due to inadequate number of cells available to form
cell lineages [35]. While the present data cannot mimic the in vivo developmental competence
of the embryo, investigation of the reproductive outcome and transgenerational risk associated
with CY exposure will be important in future studies to address the risk associated with CY
treatment in oncological patients.
Results from the present study clearly show that in addition to effects on loss of ovarian fol-
licles, the administration of CY at 14 day of life has marked effects on the subsequent ability of
oocytes to mature and fertilize, on normal early embryonic development, and on the forma-
tion of ICM outgrowths. All these adverse effects were more marked in animals exposed at the
youngest age. These findings may at least in part underlie the reduced fertility of women
despite retained ovarian function after exposure to chemotherapy in childhood. Overall, the
study provides insight into the need for fertility preservation in young prepubertal age patients
before undergoing cytotoxic chemotherapy, and the need for ongoing surveillance of their
children [1].
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